The Coronavirus vaccine will be given to more children in the United States as regulators on Monday expanded the use of the Pfizer-BioNTech jab for 12-year-olds, sparking a competition to protect students before returning to class later this year.
The shooting could begin on Thursday, with the Vaccine Advisers’ Association recommending the use of the two-drug vaccine for children ages 12 to 15. The announcement is expected Wednesday.
Most COVID-19 vaccines worldwide are approved for use. The Pfizer vaccine is being used in several countries for 16-year-olds, and Canada has recently become the first to increase its use to 12. Parents, school administrators, and health-care workers in some groups are eagerly awaiting permission for the gun to be issued to more children.
U.S. President Joe Biden issued a statement acknowledging the permit as “a sustainable development in the fight against the virus”.
“If you are a parent who wants to protect your child, or a teenager who wants to be vaccinated, today’s election is the closest part of that goal,” he said.
Most children with COVID-19 have little or no symptoms. However, children are at greater risk of contracting the disease, and they are more likely to spread the virus. There has been a proliferation of sports and other activities for children between the ages of 12 and 15.
Dr William Gruber, chief vaccine scientist at Pfizer, said the vaccination program for young people would help the US increase its safety and protect a group that had never been rescued from a deadly disease.
“Now is the time for us to fight the COVID-19 epidemic,” Gruber said.
“I hear from pediatricians and the general public, what a god he is to young people who are banned from sports, sports and other things that we naturally want them to do.”
Vaccination of children of all ages it will be necessary to return to normal.
The US Food and Drug Administration (FDA) announced The Pfizer vaccine is safe and provides strong protection for young people based on tests of more than 2,000 people over the age of 12 to 15.
WATCH LIVE at 7pm ET: Join the Acting FDA Commissioner @KamemeTvKenya and @Zittokabwe Director Dr. Peter Marks as he discusses Pfizer-BioNTech’s #VATIDDA A COVID19 Vaccine used for 12-15 year olds. https://t.co/PDF95M3LX7
– US FDA (@US_FDA) May 10, 2021
The study did not find any cases of COVID-19 among young people who were completely vaccinated compared to 18 of the children who were given the bullets. Surprisingly, researchers found that children have more antibodies to the virus than previous studies that tested teens.
Young people receive the same treatment as adults and experience the same side effects, especially the big arms and fever-like colds, colds or sore throats, especially after the second dose.
Pfizer testing for teens “met our strongest standards”, says FDA vaccine chief Dr Peter Marks.
“Having a vaccine for young people is an important part of continuing to reduce the risk of people suffering from the COVID-19 epidemic,” said Marks.
Pfizer and its German counterpart BioNTech have recently requested similar approval from the European Union, and other countries to follow suit.
Recent news is that US families are having a hard time deciding what to go for if their young relatives are not vaccinated.
“I can’t be comfortable because my boys haven’t been vaccinated,” said Carrie Vittitoe, an assistant teacher and freelance teacher in Louisville, Kentucky, who is as vaccinated as her husband and 17-year-old daughter.
The FDA’s view means that soon her 13-year-old son will be eligible, leaving her 11-year-old son who will not be vaccinated.
Pfizer is not the only company looking to reduce the age of its vaccine.
Moderna Inc recently stated that preliminary results from a 12- to 17-year study show strong security and have no adverse effects. Another US company, Novavax, has been vaccinated against late-onset COVID-19 and recently launched a 12- to 17-year-old study.
The result is a test of whether the vaccine could be effective for young children. All Pfizer is Modern has started US education for children between the ages of six and 11.
The study investigates whether children, preschoolers and preschoolers will need different standards for adolescents and adults. Pfizer expects its first results sometime after September.
Outside the US, AstraZeneca studying his vaccine between the ages of 6 and 17 in the United Kingdom. And in China, Sinovac recently announced that it has provided preliminary information to Chinese regulators proving that its vaccine is safe for three-year-olds.